 Leslie Berg
Concepts (508)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Protein-Tyrosine Kinases | 60 | 2021 | 434 | 10.270 |
Why?
| | T-Lymphocytes | 45 | 2022 | 1999 | 4.020 |
Why?
| | Receptors, Antigen, T-Cell | 41 | 2024 | 720 | 3.940 |
Why?
| | CD8-Positive T-Lymphocytes | 22 | 2020 | 917 | 3.770 |
Why?
| | Signal Transduction | 51 | 2024 | 5096 | 3.270 |
Why?
| | Cell Differentiation | 41 | 2017 | 1979 | 3.240 |
Why?
| | Lymphocyte Activation | 32 | 2024 | 1150 | 3.110 |
Why?
| | CD4-Positive T-Lymphocytes | 25 | 2016 | 1092 | 2.520 |
Why?
| | Interferon Regulatory Factors | 5 | 2020 | 37 | 2.130 |
Why?
| | Lymphocytic choriomeningitis virus | 7 | 2017 | 24 | 1.980 |
Why?
| | Thymus Gland | 24 | 2014 | 313 | 1.810 |
Why?
| | T-Lymphocyte Subsets | 13 | 2014 | 425 | 1.340 |
Why?
| | Mice | 89 | 2022 | 17843 | 1.340 |
Why?
| | Mice, Knockout | 31 | 2020 | 3020 | 1.310 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 11 | 2017 | 337 | 1.240 |
Why?
| | Animals | 109 | 2024 | 37011 | 1.210 |
Why?
| | Janus Kinase 3 | 16 | 2009 | 18 | 1.110 |
Why?
| | Intestines | 3 | 2020 | 359 | 1.090 |
Why?
| | Lymphocytic Choriomeningitis | 4 | 2015 | 14 | 1.060 |
Why?
| | Lymphocytes | 5 | 2019 | 395 | 1.020 |
Why?
| | Receptors, Antigen, T-Cell, gamma-delta | 7 | 2014 | 101 | 1.000 |
Why?
| | Mice, Inbred C57BL | 40 | 2020 | 5792 | 0.960 |
Why?
| | Proto-Oncogene Proteins c-vav | 1 | 2024 | 2 | 0.910 |
Why?
| | Th1 Cells | 4 | 2015 | 143 | 0.900 |
Why?
| | T-Box Domain Proteins | 6 | 2015 | 98 | 0.870 |
Why?
| | Immunologic Memory | 8 | 2017 | 369 | 0.860 |
Why?
| | Mice, Transgenic | 32 | 2015 | 2182 | 0.820 |
Why?
| | Cell Proliferation | 7 | 2020 | 2482 | 0.790 |
Why?
| | Interleukin Receptor Common gamma Subunit | 3 | 2019 | 14 | 0.780 |
Why?
| | Chemotaxis, Leukocyte | 3 | 2020 | 138 | 0.780 |
Why?
| | Cells, Cultured | 16 | 2021 | 4206 | 0.760 |
Why?
| | Flow Cytometry | 16 | 2022 | 1185 | 0.730 |
Why?
| | Arenaviridae Infections | 3 | 2017 | 8 | 0.700 |
Why?
| | Autoimmune Diseases | 2 | 2024 | 459 | 0.690 |
Why?
| | CD4 Antigens | 9 | 2007 | 141 | 0.680 |
Why?
| | Killer Cells, Natural | 5 | 2014 | 446 | 0.660 |
Why?
| | Calcium | 3 | 2022 | 1233 | 0.640 |
Why?
| | Transcription Factors | 11 | 2016 | 1717 | 0.590 |
Why?
| | Cytokines | 7 | 2009 | 2095 | 0.590 |
Why?
| | Natural Killer T-Cells | 3 | 2014 | 67 | 0.570 |
Why?
| | Kruppel-Like Transcription Factors | 3 | 2014 | 66 | 0.560 |
Why?
| | Influenza A virus | 3 | 2016 | 109 | 0.560 |
Why?
| | Orthomyxoviridae Infections | 2 | 2016 | 75 | 0.540 |
Why?
| | Colitis | 2 | 2019 | 265 | 0.520 |
Why?
| | Th2 Cells | 3 | 2009 | 176 | 0.510 |
Why?
| | Interleukin-2 | 9 | 2019 | 456 | 0.510 |
Why?
| | Enhancer Elements, Genetic | 2 | 2017 | 190 | 0.500 |
Why?
| | Models, Immunological | 5 | 2012 | 100 | 0.450 |
Why?
| | Molecular Sequence Data | 20 | 2015 | 2901 | 0.450 |
Why?
| | Amino Acid Sequence | 19 | 2015 | 2146 | 0.450 |
Why?
| | Repressor Proteins | 1 | 2017 | 425 | 0.430 |
Why?
| | CD28 Antigens | 5 | 2013 | 53 | 0.430 |
Why?
| | NFATC Transcription Factors | 6 | 2021 | 95 | 0.430 |
Why?
| | Interferon-gamma | 6 | 2016 | 790 | 0.420 |
Why?
| | Nuclear Proteins | 4 | 2003 | 710 | 0.420 |
Why?
| | Inflammation | 1 | 2024 | 2837 | 0.410 |
Why?
| | Ephrins | 2 | 2002 | 8 | 0.410 |
Why?
| | Receptor-CD3 Complex, Antigen, T-Cell | 3 | 2001 | 9 | 0.400 |
Why?
| | Gene Expression Regulation | 7 | 2021 | 2615 | 0.400 |
Why?
| | Allergy and Immunology | 1 | 2012 | 43 | 0.380 |
Why?
| | Histocompatibility Antigens Class I | 4 | 2010 | 203 | 0.380 |
Why?
| | Membrane Proteins | 4 | 2015 | 1167 | 0.370 |
Why?
| | Phosphorylation | 11 | 2018 | 1762 | 0.370 |
Why?
| | Protein Kinase Inhibitors | 2 | 2015 | 920 | 0.370 |
Why?
| | Antigens, CD | 6 | 2016 | 524 | 0.360 |
Why?
| | Interleukin-4 | 5 | 2014 | 217 | 0.360 |
Why?
| | Cellular Senescence | 1 | 2013 | 188 | 0.350 |
Why?
| | Epigenesis, Genetic | 2 | 2013 | 660 | 0.350 |
Why?
| | Phospholipase C gamma | 5 | 2018 | 29 | 0.340 |
Why?
| | Thymocytes | 3 | 2014 | 35 | 0.320 |
Why?
| | Adoptive Transfer | 3 | 2020 | 224 | 0.320 |
Why?
| | Proto-Oncogene Proteins c-abl | 1 | 2008 | 6 | 0.310 |
Why?
| | X-Linked Combined Immunodeficiency Diseases | 1 | 2008 | 2 | 0.310 |
Why?
| | T-Lymphocytes, Helper-Inducer | 1 | 2009 | 137 | 0.300 |
Why?
| | Major Histocompatibility Complex | 5 | 1997 | 231 | 0.300 |
Why?
| | Apoptosis | 6 | 2014 | 2557 | 0.300 |
Why?
| | Sequence Homology, Amino Acid | 5 | 2013 | 387 | 0.290 |
Why?
| | Receptor Protein-Tyrosine Kinases | 1 | 2010 | 235 | 0.290 |
Why?
| | Protein Interaction Domains and Motifs | 2 | 2019 | 151 | 0.290 |
Why?
| | Phosphoproteins | 2 | 2001 | 338 | 0.280 |
Why?
| | Interleukin-15 | 4 | 2014 | 97 | 0.280 |
Why?
| | src-Family Kinases | 3 | 2018 | 94 | 0.280 |
Why?
| | src Homology Domains | 5 | 2003 | 40 | 0.280 |
Why?
| | CD8 Antigens | 6 | 2007 | 75 | 0.270 |
Why?
| | Tyrosine | 4 | 2013 | 224 | 0.270 |
Why?
| | Cell Lineage | 7 | 2015 | 346 | 0.270 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2008 | 106 | 0.270 |
Why?
| | Immunoglobulin E | 1 | 2009 | 341 | 0.270 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2009 | 379 | 0.270 |
Why?
| | Promyelocytic Leukemia Zinc Finger Protein | 3 | 2014 | 7 | 0.260 |
Why?
| | Cell Cycle | 1 | 2009 | 604 | 0.250 |
Why?
| | Receptors, Eph Family | 2 | 2002 | 6 | 0.250 |
Why?
| | Cytotoxicity, Immunologic | 3 | 2016 | 225 | 0.250 |
Why?
| | Antigens, Differentiation | 3 | 2004 | 83 | 0.250 |
Why?
| | Lymphopenia | 2 | 2008 | 61 | 0.240 |
Why?
| | Mast Cells | 1 | 2007 | 146 | 0.240 |
Why?
| | B-Lymphocytes | 4 | 2009 | 847 | 0.240 |
Why?
| | Humans | 38 | 2024 | 137514 | 0.230 |
Why?
| | Up-Regulation | 6 | 2014 | 846 | 0.220 |
Why?
| | Antigens, CD1d | 2 | 2014 | 68 | 0.220 |
Why?
| | Autoimmunity | 2 | 2024 | 907 | 0.220 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2014 | 974 | 0.220 |
Why?
| | Ligands | 8 | 2009 | 665 | 0.220 |
Why?
| | Gene Expression | 5 | 2014 | 1505 | 0.220 |
Why?
| | Enzyme Activation | 6 | 2010 | 816 | 0.210 |
Why?
| | Receptor, EphA1 | 1 | 2002 | 2 | 0.200 |
Why?
| | Receptors, Lymphocyte Homing | 2 | 2020 | 16 | 0.200 |
Why?
| | Homeostasis | 3 | 2013 | 622 | 0.200 |
Why?
| | Phosphatidylinositol 3-Kinases | 3 | 2002 | 366 | 0.200 |
Why?
| | MAP Kinase Signaling System | 2 | 2021 | 322 | 0.200 |
Why?
| | Epstein-Barr Virus Infections | 1 | 2024 | 99 | 0.200 |
Why?
| | Histocompatibility Antigens Class II | 4 | 1999 | 368 | 0.200 |
Why?
| | Cytoplasm | 2 | 2022 | 274 | 0.200 |
Why?
| | Interleukin-17 | 3 | 2013 | 120 | 0.200 |
Why?
| | Down-Regulation | 3 | 2010 | 658 | 0.200 |
Why?
| | Membrane Glycoproteins | 2 | 2002 | 501 | 0.200 |
Why?
| | Stomach Neoplasms | 1 | 2024 | 126 | 0.190 |
Why?
| | Jurkat Cells | 6 | 2009 | 134 | 0.190 |
Why?
| | Cell Line | 7 | 2015 | 2852 | 0.190 |
Why?
| | Type C Phospholipases | 4 | 2003 | 75 | 0.190 |
Why?
| | Gene Expression Regulation, Developmental | 3 | 2004 | 856 | 0.190 |
Why?
| | Immunophenotyping | 5 | 2016 | 321 | 0.180 |
Why?
| | H-2 Antigens | 3 | 2014 | 115 | 0.180 |
Why?
| | NF-kappa B | 2 | 2021 | 694 | 0.180 |
Why?
| | CD3 Complex | 2 | 2009 | 106 | 0.180 |
Why?
| | Promoter Regions, Genetic | 4 | 2014 | 1255 | 0.180 |
Why?
| | Male | 17 | 2021 | 67718 | 0.180 |
Why?
| | Stem Cells | 3 | 2001 | 589 | 0.180 |
Why?
| | Molecular Targeted Therapy | 1 | 2024 | 414 | 0.180 |
Why?
| | Polymerase Chain Reaction | 4 | 2017 | 1061 | 0.180 |
Why?
| | Receptors, Immunologic | 1 | 2002 | 223 | 0.170 |
Why?
| | Hematopoiesis | 4 | 2010 | 190 | 0.170 |
Why?
| | Positive Regulatory Domain I-Binding Factor 1 | 3 | 2016 | 18 | 0.170 |
Why?
| | Tacrolimus | 1 | 2001 | 199 | 0.170 |
Why?
| | Hematopoietic Stem Cells | 4 | 1999 | 398 | 0.170 |
Why?
| | Rhadinovirus | 1 | 2020 | 21 | 0.160 |
Why?
| | History, 21st Century | 2 | 2012 | 211 | 0.160 |
Why?
| | History, 20th Century | 2 | 2012 | 324 | 0.160 |
Why?
| | Protein Binding | 6 | 2018 | 2229 | 0.160 |
Why?
| | Antigens, Differentiation, T-Lymphocyte | 4 | 2016 | 98 | 0.160 |
Why?
| | Immunoconjugates | 1 | 2001 | 116 | 0.160 |
Why?
| | Spleen | 4 | 2014 | 516 | 0.160 |
Why?
| | Cricetinae | 3 | 2015 | 288 | 0.160 |
Why?
| | Adaptor Proteins, Signal Transducing | 2 | 2000 | 429 | 0.160 |
Why?
| | Receptors, Cytokine | 1 | 1999 | 36 | 0.160 |
Why?
| | Sea Urchins | 2 | 1998 | 7 | 0.160 |
Why?
| | Blood Proteins | 1 | 2001 | 250 | 0.150 |
Why?
| | Interleukin-33 | 1 | 2019 | 49 | 0.150 |
Why?
| | Hepatocyte Nuclear Factor 1-alpha | 2 | 2015 | 17 | 0.150 |
Why?
| | Chronic Disease | 1 | 2024 | 1790 | 0.140 |
Why?
| | DNA-Binding Proteins | 5 | 2006 | 1507 | 0.140 |
Why?
| | DNA | 3 | 2021 | 1460 | 0.140 |
Why?
| | Base Sequence | 6 | 1997 | 2180 | 0.140 |
Why?
| | Recombinant Fusion Proteins | 6 | 2001 | 665 | 0.140 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2017 | 139 | 0.140 |
Why?
| | NK Cell Lectin-Like Receptor Subfamily C | 1 | 2016 | 8 | 0.130 |
Why?
| | Immunologic Deficiency Syndromes | 1 | 1997 | 69 | 0.130 |
Why?
| | Virus Replication | 1 | 2020 | 480 | 0.130 |
Why?
| | Peptide Fragments | 4 | 1997 | 708 | 0.130 |
Why?
| | Clonal Deletion | 4 | 2001 | 16 | 0.130 |
Why?
| | Phenotype | 5 | 2006 | 3205 | 0.130 |
Why?
| | Lymph Nodes | 2 | 2014 | 493 | 0.130 |
Why?
| | Seals, Earless | 2 | 2006 | 5 | 0.130 |
Why?
| | Hematopoietic System | 1 | 1996 | 8 | 0.130 |
Why?
| | Methylation | 2 | 2014 | 237 | 0.130 |
Why?
| | Microscopy, Confocal | 1 | 2017 | 327 | 0.130 |
Why?
| | Mutation | 5 | 2013 | 3964 | 0.130 |
Why?
| | Mass Spectrometry | 1 | 2019 | 741 | 0.130 |
Why?
| | Biomarkers | 4 | 2024 | 4172 | 0.120 |
Why?
| | Chemokine CCL20 | 1 | 2015 | 5 | 0.120 |
Why?
| | Chemokine CXCL11 | 1 | 2015 | 3 | 0.120 |
Why?
| | Homeodomain Proteins | 2 | 2019 | 504 | 0.120 |
Why?
| | Binding Sites | 7 | 2013 | 1310 | 0.120 |
Why?
| | Lymphoid Tissue | 1 | 1996 | 75 | 0.120 |
Why?
| | Receptors, Interleukin-7 | 3 | 2001 | 28 | 0.120 |
Why?
| | Introns | 1 | 1997 | 256 | 0.120 |
Why?
| | Exons | 1 | 1997 | 349 | 0.120 |
Why?
| | Germinal Center | 1 | 2015 | 58 | 0.120 |
Why?
| | Interferon Type I | 1 | 2016 | 142 | 0.120 |
Why?
| | Female | 16 | 2021 | 73162 | 0.120 |
Why?
| | Protein Structure, Tertiary | 4 | 2013 | 869 | 0.120 |
Why?
| | Oligopeptides | 1 | 1996 | 273 | 0.110 |
Why?
| | Animal Structures | 1 | 2014 | 9 | 0.110 |
Why?
| | Cell Survival | 3 | 2014 | 1122 | 0.110 |
Why?
| | Th17 Cells | 1 | 2015 | 109 | 0.110 |
Why?
| | beta 2-Microglobulin | 1 | 2014 | 50 | 0.110 |
Why?
| | Annexin A2 | 1 | 2014 | 11 | 0.110 |
Why?
| | S100 Proteins | 1 | 2014 | 37 | 0.110 |
Why?
| | Cell Movement | 2 | 2013 | 972 | 0.110 |
Why?
| | Prion Diseases | 1 | 1994 | 16 | 0.110 |
Why?
| | Spodoptera | 3 | 2010 | 40 | 0.110 |
Why?
| | Citalopram | 1 | 2014 | 32 | 0.110 |
Why?
| | Transfection | 4 | 2001 | 948 | 0.110 |
Why?
| | Histone Deacetylase 2 | 1 | 2013 | 10 | 0.110 |
Why?
| | Cytochrome c Group | 4 | 2002 | 43 | 0.110 |
Why?
| | Tumor Necrosis Factor Receptor Superfamily, Member 7 | 1 | 2013 | 28 | 0.110 |
Why?
| | Polycomb Repressive Complex 2 | 1 | 2014 | 66 | 0.100 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 1 | 2013 | 84 | 0.100 |
Why?
| | Cell Migration Inhibition | 1 | 2013 | 17 | 0.100 |
Why?
| | Resting Phase, Cell Cycle | 2 | 2010 | 15 | 0.100 |
Why?
| | Mice, Mutant Strains | 2 | 2008 | 300 | 0.100 |
Why?
| | High Mobility Group Proteins | 1 | 2013 | 44 | 0.100 |
Why?
| | Lymphocyte Subsets | 1 | 2013 | 87 | 0.100 |
Why?
| | Receptors, Antigen, B-Cell | 1 | 2013 | 130 | 0.100 |
Why?
| | Animals, Newborn | 3 | 2006 | 845 | 0.090 |
Why?
| | Antidepressive Agents | 1 | 2014 | 239 | 0.090 |
Why?
| | Forkhead Transcription Factors | 1 | 2012 | 191 | 0.090 |
Why?
| | Histone-Lysine N-Methyltransferase | 1 | 2013 | 141 | 0.090 |
Why?
| | Histones | 2 | 2014 | 641 | 0.090 |
Why?
| | Acute Disease | 1 | 2014 | 1008 | 0.090 |
Why?
| | Autoantigens | 2 | 2013 | 429 | 0.090 |
Why?
| | Transcription, Genetic | 4 | 2015 | 1458 | 0.090 |
Why?
| | RNA, Small Interfering | 1 | 2013 | 621 | 0.090 |
Why?
| | Monocytes | 1 | 2014 | 568 | 0.090 |
Why?
| | Arthritis, Rheumatoid | 1 | 2000 | 1163 | 0.090 |
Why?
| | Kinetics | 4 | 2013 | 1679 | 0.090 |
Why?
| | Transplantation Chimera | 1 | 2010 | 54 | 0.080 |
Why?
| | Isoenzymes | 2 | 2002 | 305 | 0.080 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2011 | 156 | 0.080 |
Why?
| | Mitogen-Activated Protein Kinases | 2 | 2002 | 316 | 0.080 |
Why?
| | Depressive Disorder, Major | 1 | 2014 | 366 | 0.080 |
Why?
| | Interferon-beta | 1 | 2010 | 92 | 0.080 |
Why?
| | Alleles | 2 | 1990 | 891 | 0.080 |
Why?
| | Mitosis | 1 | 2011 | 193 | 0.080 |
Why?
| | Phosphotyrosine | 2 | 2001 | 38 | 0.080 |
Why?
| | Transcription Factors, TFII | 1 | 2009 | 41 | 0.080 |
Why?
| | Cell Line, Tumor | 2 | 2009 | 3420 | 0.080 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2012 | 392 | 0.080 |
Why?
| | Cord Blood Stem Cell Transplantation | 1 | 2010 | 99 | 0.080 |
Why?
| | Immunoglobulin Class Switching | 1 | 2009 | 20 | 0.080 |
Why?
| | Apnea | 2 | 2006 | 22 | 0.080 |
Why?
| | DNA, Complementary | 4 | 2001 | 269 | 0.080 |
Why?
| | T-Lymphocytes, Cytotoxic | 3 | 1996 | 173 | 0.080 |
Why?
| | Herpesvirus 2, Human | 1 | 2009 | 28 | 0.080 |
Why?
| | Interferon-alpha | 1 | 2010 | 198 | 0.080 |
Why?
| | Immediate-Early Proteins | 1 | 2009 | 50 | 0.080 |
Why?
| | Rats | 2 | 2014 | 5676 | 0.080 |
Why?
| | Xenopus Proteins | 2 | 2006 | 37 | 0.080 |
Why?
| | GPI-Linked Proteins | 1 | 2009 | 71 | 0.080 |
Why?
| | Genes | 1 | 1988 | 230 | 0.070 |
Why?
| | Societies, Medical | 1 | 2012 | 820 | 0.070 |
Why?
| | STAT Transcription Factors | 1 | 2008 | 16 | 0.070 |
Why?
| | Structure-Activity Relationship | 2 | 2001 | 586 | 0.070 |
Why?
| | Neoplasm Transplantation | 1 | 2008 | 256 | 0.070 |
Why?
| | Atrophy | 1 | 2008 | 184 | 0.070 |
Why?
| | Herpes Simplex | 1 | 2009 | 93 | 0.070 |
Why?
| | STAT5 Transcription Factor | 1 | 2008 | 57 | 0.070 |
Why?
| | Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 3 | 1997 | 21 | 0.070 |
Why?
| | Organ Culture Techniques | 2 | 2001 | 156 | 0.070 |
Why?
| | Time Factors | 5 | 2010 | 6817 | 0.070 |
Why?
| | Herpesvirus 1, Human | 1 | 2009 | 86 | 0.070 |
Why?
| | Conserved Sequence | 3 | 1998 | 239 | 0.070 |
Why?
| | CD5 Antigens | 2 | 2002 | 10 | 0.070 |
Why?
| | Mice, Inbred C3H | 2 | 1999 | 272 | 0.070 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2009 | 179 | 0.070 |
Why?
| | Clone Cells | 2 | 2001 | 266 | 0.070 |
Why?
| | Multigene Family | 1 | 2008 | 202 | 0.070 |
Why?
| | Tissue Donors | 1 | 2010 | 417 | 0.070 |
Why?
| | CTLA-4 Antigen | 2 | 2013 | 99 | 0.070 |
Why?
| | Severe Combined Immunodeficiency | 2 | 1997 | 20 | 0.070 |
Why?
| | HeLa Cells | 1 | 2009 | 640 | 0.070 |
Why?
| | Antigens, Surface | 2 | 2014 | 154 | 0.070 |
Why?
| | Disease Models, Animal | 1 | 2017 | 4295 | 0.070 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2008 | 285 | 0.070 |
Why?
| | Disease Susceptibility | 1 | 2008 | 344 | 0.070 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 849 | 0.060 |
Why?
| | Mutagenesis, Site-Directed | 2 | 1997 | 377 | 0.060 |
Why?
| | Macromolecular Substances | 2 | 2001 | 227 | 0.060 |
Why?
| | Bone Marrow Cells | 3 | 2014 | 313 | 0.060 |
Why?
| | Mice, Inbred BALB C | 5 | 2016 | 1271 | 0.060 |
Why?
| | Hyaluronan Receptors | 1 | 2006 | 103 | 0.060 |
Why?
| | Veins | 1 | 2006 | 63 | 0.060 |
Why?
| | Disease Progression | 1 | 2013 | 2755 | 0.060 |
Why?
| | Immunity, Innate | 2 | 2013 | 832 | 0.060 |
Why?
| | Transcriptome | 1 | 2012 | 974 | 0.060 |
Why?
| | Cardiac Output | 1 | 2006 | 164 | 0.060 |
Why?
| | Lysine | 2 | 2014 | 297 | 0.060 |
Why?
| | Lectins, C-Type | 2 | 2016 | 72 | 0.060 |
Why?
| | RNA, Messenger | 4 | 1998 | 2838 | 0.060 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2005 | 72 | 0.060 |
Why?
| | Glycogen Synthase Kinase 3 | 1 | 2005 | 82 | 0.060 |
Why?
| | Genetic Variation | 1 | 1990 | 986 | 0.060 |
Why?
| | Alternative Splicing | 2 | 1997 | 227 | 0.060 |
Why?
| | Protein Conformation | 3 | 2000 | 930 | 0.060 |
Why?
| | Molecular Structure | 1 | 2005 | 508 | 0.050 |
Why?
| | Point Mutation | 2 | 2010 | 234 | 0.050 |
Why?
| | Leukosialin | 2 | 2009 | 14 | 0.050 |
Why?
| | Proto-Oncogene Proteins | 2 | 2005 | 646 | 0.050 |
Why?
| | In Vitro Techniques | 1 | 2005 | 1108 | 0.050 |
Why?
| | Herpesvirus 4, Human | 1 | 2024 | 167 | 0.050 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2005 | 437 | 0.050 |
Why?
| | Signaling Lymphocytic Activation Molecule Family | 1 | 2002 | 7 | 0.050 |
Why?
| | Dose-Response Relationship, Immunologic | 1 | 2002 | 82 | 0.050 |
Why?
| | Genes, T-Cell Receptor | 1 | 2002 | 9 | 0.050 |
Why?
| | Heart | 1 | 2006 | 660 | 0.050 |
Why?
| | Hybridomas | 2 | 2000 | 237 | 0.050 |
Why?
| | Fas Ligand Protein | 1 | 2002 | 59 | 0.050 |
Why?
| | ZAP-70 Protein-Tyrosine Kinase | 1 | 2001 | 10 | 0.050 |
Why?
| | Tacrolimus Binding Protein 1A | 1 | 2001 | 10 | 0.050 |
Why?
| | Antigen-Presenting Cells | 1 | 2002 | 156 | 0.050 |
Why?
| | Cysteine | 2 | 2001 | 206 | 0.050 |
Why?
| | B7-H1 Antigen | 1 | 2024 | 218 | 0.050 |
Why?
| | Transgenes | 1 | 2002 | 180 | 0.050 |
Why?
| | Fetus | 2 | 2012 | 807 | 0.050 |
Why?
| | Dimerization | 1 | 2001 | 198 | 0.050 |
Why?
| | Embryo, Nonmammalian | 2 | 2001 | 167 | 0.050 |
Why?
| | Gene Rearrangement, T-Lymphocyte | 1 | 2001 | 15 | 0.040 |
Why?
| | Amino Acid Motifs | 1 | 2001 | 225 | 0.040 |
Why?
| | Genes, Reporter | 1 | 2001 | 268 | 0.040 |
Why?
| | Injections, Intralymphatic | 1 | 2000 | 1 | 0.040 |
Why?
| | Bone Morphogenetic Proteins | 1 | 2001 | 135 | 0.040 |
Why?
| | Abatacept | 1 | 2001 | 53 | 0.040 |
Why?
| | Cross-Linking Reagents | 1 | 2001 | 212 | 0.040 |
Why?
| | Mice, Congenic | 1 | 2000 | 23 | 0.040 |
Why?
| | Phosphatidylinositol Phosphates | 1 | 2001 | 39 | 0.040 |
Why?
| | Cell Division | 2 | 2000 | 795 | 0.040 |
Why?
| | Calcium Signaling | 1 | 2003 | 253 | 0.040 |
Why?
| | Stromal Cells | 1 | 2001 | 111 | 0.040 |
Why?
| | Embryonic and Fetal Development | 1 | 2000 | 96 | 0.040 |
Why?
| | Androstadienes | 1 | 2001 | 107 | 0.040 |
Why?
| | Synovial Fluid | 1 | 2000 | 69 | 0.040 |
Why?
| | Granulocytes | 1 | 2000 | 80 | 0.040 |
Why?
| | Enzyme Inhibitors | 2 | 2001 | 845 | 0.040 |
Why?
| | Interphase | 1 | 1999 | 32 | 0.040 |
Why?
| | Detergents | 1 | 2000 | 44 | 0.040 |
Why?
| | Cell Line, Transformed | 2 | 1999 | 145 | 0.040 |
Why?
| | Amino Acid Substitution | 1 | 2001 | 309 | 0.040 |
Why?
| | Leukopoiesis | 1 | 1999 | 11 | 0.040 |
Why?
| | Antibodies, Blocking | 1 | 1999 | 33 | 0.040 |
Why?
| | Immune Tolerance | 2 | 1994 | 362 | 0.040 |
Why?
| | Stem Cell Factor | 1 | 1999 | 15 | 0.040 |
Why?
| | Arginine | 1 | 2001 | 274 | 0.040 |
Why?
| | Bone Marrow Transplantation | 1 | 2000 | 286 | 0.040 |
Why?
| | Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor | 1 | 1998 | 8 | 0.040 |
Why?
| | Chemokines, CXC | 1 | 1999 | 70 | 0.040 |
Why?
| | Blood Pressure | 1 | 2006 | 1776 | 0.040 |
Why?
| | Chemokine CXCL12 | 1 | 1999 | 80 | 0.040 |
Why?
| | Interleukin-7 | 1 | 1999 | 62 | 0.040 |
Why?
| | Glutamic Acid | 1 | 2001 | 249 | 0.040 |
Why?
| | Tumor Cells, Cultured | 2 | 1999 | 957 | 0.040 |
Why?
| | Biological Transport | 1 | 1999 | 416 | 0.040 |
Why?
| | Cricetulus | 2 | 2013 | 110 | 0.040 |
Why?
| | Ion Transport | 1 | 1998 | 62 | 0.040 |
Why?
| | Hyalin | 1 | 1998 | 6 | 0.040 |
Why?
| | Gene Rearrangement | 1 | 1999 | 151 | 0.040 |
Why?
| | Vanadates | 1 | 1997 | 14 | 0.040 |
Why?
| | Phosphopeptides | 1 | 1997 | 20 | 0.040 |
Why?
| | Lymphocyte Count | 1 | 1997 | 150 | 0.030 |
Why?
| | Selection, Genetic | 2 | 1989 | 262 | 0.030 |
Why?
| | Receptors, Interleukin-2 | 2 | 1999 | 66 | 0.030 |
Why?
| | Molecular Weight | 2 | 1999 | 332 | 0.030 |
Why?
| | Antibodies, Monoclonal | 3 | 1999 | 1428 | 0.030 |
Why?
| | Recombinant Proteins | 2 | 1997 | 1357 | 0.030 |
Why?
| | Receptor, EphB6 | 1 | 1996 | 1 | 0.030 |
Why?
| | Species Specificity | 2 | 2006 | 593 | 0.030 |
Why?
| | Antigens, Neoplasm | 1 | 1999 | 322 | 0.030 |
Why?
| | Gene Deletion | 2 | 1999 | 393 | 0.030 |
Why?
| | Receptors, Interleukin | 1 | 1996 | 45 | 0.030 |
Why?
| | Agammaglobulinemia | 1 | 1996 | 34 | 0.030 |
Why?
| | Homozygote | 1 | 1997 | 203 | 0.030 |
Why?
| | Enzyme Induction | 1 | 1996 | 90 | 0.030 |
Why?
| | Immunoglobulin Fab Fragments | 1 | 1996 | 59 | 0.030 |
Why?
| | Mice, SCID | 2 | 2013 | 367 | 0.030 |
Why?
| | Poly I-C | 1 | 2016 | 63 | 0.030 |
Why?
| | Chickens | 1 | 1996 | 192 | 0.030 |
Why?
| | Blotting, Western | 2 | 2013 | 1227 | 0.030 |
Why?
| | Muscle, Skeletal | 1 | 2006 | 1701 | 0.030 |
Why?
| | Receptors, CXCR5 | 1 | 2015 | 21 | 0.030 |
Why?
| | Leukocyte Common Antigens | 1 | 1995 | 87 | 0.030 |
Why?
| | Cloning, Molecular | 2 | 1995 | 536 | 0.030 |
Why?
| | Gene Targeting | 1 | 1995 | 83 | 0.030 |
Why?
| | Crosses, Genetic | 1 | 2015 | 137 | 0.030 |
Why?
| | Carrier Proteins | 1 | 2000 | 770 | 0.030 |
Why?
| | Sequence Alignment | 1 | 1996 | 345 | 0.030 |
Why?
| | Organ Specificity | 1 | 1996 | 304 | 0.030 |
Why?
| | Sialoglycoproteins | 1 | 1995 | 159 | 0.030 |
Why?
| | Feedback, Physiological | 1 | 2015 | 78 | 0.030 |
Why?
| | Interferon Regulatory Factor-3 | 1 | 2015 | 17 | 0.030 |
Why?
| | Consensus Sequence | 1 | 1995 | 73 | 0.030 |
Why?
| | Ovum | 1 | 1995 | 30 | 0.030 |
Why?
| | Ribonucleases | 1 | 1995 | 55 | 0.030 |
Why?
| | Adult | 3 | 2014 | 37821 | 0.030 |
Why?
| | Lasers | 1 | 1995 | 137 | 0.030 |
Why?
| | Protein Processing, Post-Translational | 1 | 1997 | 471 | 0.030 |
Why?
| | Zinc Fingers | 1 | 2014 | 50 | 0.030 |
Why?
| | Stochastic Processes | 1 | 1994 | 71 | 0.030 |
Why?
| | Dendritic Cells | 2 | 2015 | 488 | 0.030 |
Why?
| | Epitopes | 1 | 1996 | 481 | 0.030 |
Why?
| | Immunosuppressive Agents | 1 | 1999 | 891 | 0.030 |
Why?
| | Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 1 | 1994 | 21 | 0.030 |
Why?
| | Scrapie | 1 | 1994 | 4 | 0.030 |
Why?
| | PrPSc Proteins | 1 | 1994 | 9 | 0.030 |
Why?
| | Biomarkers, Pharmacological | 1 | 2014 | 28 | 0.030 |
Why?
| | Immunoglobulin M | 1 | 1995 | 288 | 0.030 |
Why?
| | CD4-CD8 Ratio | 1 | 1994 | 22 | 0.030 |
Why?
| | Regional Blood Flow | 2 | 2006 | 474 | 0.030 |
Why?
| | DNA Primers | 1 | 1995 | 514 | 0.030 |
Why?
| | Sf9 Cells | 1 | 2013 | 9 | 0.030 |
Why?
| | Viral Proteins | 1 | 1996 | 346 | 0.030 |
Why?
| | Deuterium Exchange Measurement | 1 | 2013 | 30 | 0.030 |
Why?
| | Prions | 1 | 1994 | 48 | 0.030 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 1995 | 171 | 0.030 |
Why?
| | CHO Cells | 1 | 2013 | 161 | 0.030 |
Why?
| | Natural Cytotoxicity Triggering Receptor 1 | 1 | 2013 | 2 | 0.030 |
Why?
| | SOXC Transcription Factors | 1 | 2013 | 5 | 0.030 |
Why?
| | Lymphoid Enhancer-Binding Factor 1 | 1 | 2013 | 6 | 0.030 |
Why?
| | Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2013 | 14 | 0.030 |
Why?
| | Interferons | 1 | 2015 | 199 | 0.030 |
Why?
| | Biocatalysis | 1 | 2013 | 69 | 0.030 |
Why?
| | Middle Aged | 2 | 2009 | 33355 | 0.030 |
Why?
| | Genes, abl | 1 | 1993 | 3 | 0.030 |
Why?
| | Genes, src | 1 | 1993 | 5 | 0.030 |
Why?
| | Antigens, Ly | 1 | 2013 | 44 | 0.030 |
Why?
| | Cell Separation | 1 | 2014 | 320 | 0.030 |
Why?
| | Evolution, Molecular | 1 | 1997 | 488 | 0.020 |
Why?
| | CD24 Antigen | 1 | 2012 | 20 | 0.020 |
Why?
| | Tissue Distribution | 1 | 1993 | 330 | 0.020 |
Why?
| | Host-Pathogen Interactions | 1 | 2015 | 367 | 0.020 |
Why?
| | Young Adult | 1 | 2009 | 13243 | 0.020 |
Why?
| | Macrophages | 1 | 2000 | 1548 | 0.020 |
Why?
| | Haplotypes | 1 | 1994 | 491 | 0.020 |
Why?
| | Models, Molecular | 2 | 2013 | 1586 | 0.020 |
Why?
| | Heart Rate | 2 | 2006 | 831 | 0.020 |
Why?
| | Mice, Inbred NOD | 1 | 2013 | 601 | 0.020 |
Why?
| | Principal Component Analysis | 1 | 2012 | 197 | 0.020 |
Why?
| | Interleukins | 1 | 2013 | 251 | 0.020 |
Why?
| | Transcriptional Activation | 1 | 2013 | 379 | 0.020 |
Why?
| | Precipitin Tests | 2 | 2001 | 100 | 0.020 |
Why?
| | Pichinde virus | 1 | 2010 | 1 | 0.020 |
Why?
| | H-Y Antigen | 1 | 2010 | 7 | 0.020 |
Why?
| | Gene Regulatory Networks | 1 | 2013 | 308 | 0.020 |
Why?
| | Peptides | 2 | 1996 | 986 | 0.020 |
Why?
| | K562 Cells | 1 | 2010 | 89 | 0.020 |
Why?
| | Mitogens | 1 | 2010 | 61 | 0.020 |
Why?
| | Bystander Effect | 1 | 2010 | 16 | 0.020 |
Why?
| | Baculoviridae | 1 | 2010 | 44 | 0.020 |
Why?
| | Cell Polarity | 1 | 2011 | 141 | 0.020 |
Why?
| | Autoantibodies | 2 | 2015 | 1501 | 0.020 |
Why?
| | NIH 3T3 Cells | 1 | 2010 | 144 | 0.020 |
Why?
| | T-Cell Antigen Receptor Specificity | 1 | 1989 | 51 | 0.020 |
Why?
| | Genes, fos | 1 | 2009 | 36 | 0.020 |
Why?
| | Adolescent | 1 | 2009 | 21555 | 0.020 |
Why?
| | Proteins | 1 | 1995 | 1012 | 0.020 |
Why?
| | Pseudogenes | 1 | 1988 | 19 | 0.020 |
Why?
| | Blotting, Southern | 1 | 1988 | 72 | 0.020 |
Why?
| | RNA-Binding Proteins | 1 | 1992 | 424 | 0.020 |
Why?
| | Mycobacterium tuberculosis | 1 | 2012 | 317 | 0.020 |
Why?
| | Genetic Vectors | 1 | 2010 | 322 | 0.020 |
Why?
| | Mice, Inbred Strains | 1 | 1988 | 413 | 0.020 |
Why?
| | Age Factors | 2 | 2012 | 3301 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2000 | 7593 | 0.020 |
Why?
| | MicroRNAs | 1 | 2014 | 704 | 0.020 |
Why?
| | Polymorphism, Genetic | 1 | 1990 | 658 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2010 | 1242 | 0.010 |
Why?
| | Models, Cardiovascular | 1 | 2006 | 195 | 0.010 |
Why?
| | Arteries | 1 | 2006 | 269 | 0.010 |
Why?
| | Brain | 1 | 1996 | 2831 | 0.010 |
Why?
| | Lung | 1 | 2016 | 4066 | 0.010 |
Why?
| | Temperature | 1 | 2006 | 680 | 0.010 |
Why?
| | Stroke Volume | 1 | 2006 | 619 | 0.010 |
Why?
| | Aging | 1 | 1993 | 1866 | 0.010 |
Why?
| | Subtilisins | 1 | 2001 | 10 | 0.010 |
Why?
| | Furin | 1 | 2001 | 14 | 0.010 |
Why?
| | Xenopus | 1 | 2001 | 87 | 0.010 |
Why?
| | beta-Galactosidase | 1 | 2001 | 78 | 0.010 |
Why?
| | Bone Morphogenetic Protein 4 | 1 | 2001 | 43 | 0.010 |
Why?
| | Aged | 1 | 2000 | 23798 | 0.010 |
Why?
| | Pulmonary Artery | 1 | 2006 | 1083 | 0.010 |
Why?
| | Cell Aggregation | 1 | 1999 | 26 | 0.010 |
Why?
| | Glycosylphosphatidylinositols | 1 | 1999 | 12 | 0.010 |
Why?
| | Tetradecanoylphorbol Acetate | 1 | 1999 | 151 | 0.010 |
Why?
| | Lymphoma, T-Cell | 1 | 1999 | 25 | 0.010 |
Why?
| | Receptors, IgG | 1 | 1999 | 75 | 0.010 |
Why?
| | Genes, RAG-1 | 1 | 1998 | 12 | 0.010 |
Why?
| | Hydroxamic Acids | 1 | 1998 | 89 | 0.010 |
Why?
| | Cell Death | 1 | 1999 | 370 | 0.010 |
Why?
| | Repetitive Sequences, Nucleic Acid | 1 | 1998 | 113 | 0.010 |
Why?
| | Ectoderm | 1 | 1998 | 53 | 0.010 |
Why?
| | Histone Deacetylases | 1 | 1998 | 215 | 0.010 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 1998 | 211 | 0.010 |
Why?
| | Receptor Aggregation | 1 | 1996 | 11 | 0.010 |
Why?
| | Receptors, Interleukin-4 | 1 | 1996 | 16 | 0.010 |
Why?
| | Immunologic Techniques | 1 | 1996 | 40 | 0.010 |
Why?
| | Janus Kinase 1 | 1 | 1996 | 24 | 0.010 |
Why?
| | Proline | 1 | 1997 | 80 | 0.010 |
Why?
| | Cell Adhesion | 1 | 1998 | 467 | 0.010 |
Why?
| | Binding, Competitive | 1 | 1996 | 211 | 0.010 |
Why?
| | Vaccines, Synthetic | 1 | 1996 | 126 | 0.010 |
Why?
| | Ovary | 1 | 1998 | 218 | 0.010 |
Why?
| | Rosaniline Dyes | 1 | 1995 | 12 | 0.010 |
Why?
| | GRB2 Adaptor Protein | 1 | 1995 | 13 | 0.010 |
Why?
| | Proto-Oncogene Proteins c-fyn | 1 | 1995 | 12 | 0.010 |
Why?
| | Phosphotransferases (Alcohol Group Acceptor) | 1 | 1995 | 45 | 0.010 |
Why?
| | Coloring Agents | 1 | 1995 | 86 | 0.010 |
Why?
| | Photochemistry | 1 | 1995 | 135 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 1999 | 1740 | 0.010 |
Why?
| | Chromatin | 1 | 1998 | 524 | 0.010 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 1997 | 619 | 0.010 |
Why?
| | Immunization, Passive | 1 | 1994 | 90 | 0.010 |
Why?
| | DNA Methylation | 1 | 1998 | 644 | 0.010 |
Why?
| | Nucleocapsid Proteins | 1 | 1992 | 24 | 0.010 |
Why?
| | Viral Core Proteins | 1 | 1992 | 21 | 0.010 |
Why?
| | Nucleoproteins | 1 | 1992 | 29 | 0.010 |
Why?
| | Escherichia coli | 1 | 1997 | 815 | 0.010 |
Why?
| | ErbB Receptors | 1 | 1995 | 616 | 0.010 |
Why?
| | RNA | 1 | 1998 | 924 | 0.010 |
Why?
| | Immunization | 1 | 1992 | 414 | 0.010 |
Why?
| | Histocompatibility Antigens | 1 | 1989 | 107 | 0.000 |
Why?
|
|
Berg's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|